Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth, Scottish Enterprise Pledge $86M for New Translational Research Collaboration

NEW YORK, April 12 (GenomeWeb News) - Scotland's economic development agency Scottish Enterprise and Wyeth Pharmaceuticals plan to set up a translational medicine research collaboration in Scotland, the groups said last week.


According to Scottish Enterprise, Wyeth will invest approximately $57 million, while the agency has pledged up to $30 million over the next five years. 


The collaboration will pair Wyeth and National Health Service Scotland with the Universities of Aberdeen, Dundee, Edinburgh, and Glasgow, in an effort to use Scottish resources to develop new drugs and diagnostics, with an emphasis on clinical trials.


Specifically, the partnership will create a 50-employee central research lab at the University of Dundee to coordinate clinical research with labs at the other member universities.


Wyeth and Scottish Enterprise said they have the option to extend their collaboration for another five years after the first period of the project concludes.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.